Nuclear factor-κB1:: Regulation and function

被引:175
作者
Pereira, Silvia Gaspar [1 ]
Oakley, Fiona [1 ]
机构
[1] Univ Newcastle, Inst Cellular Med, Liver Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
基金
英国惠康基金; 英国医学研究理事会;
关键词
p50; p105; signaling; function;
D O I
10.1016/j.biocel.2007.05.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The transcription factor NF-kappa B is a critical regulator of many cellular processes including cell survival and inflammation. NF-kappa B functions as a hetero- or homo-dimer which can be formed from five NF-kappa B subunits, NF-kappa B1 (p50 and its precursor p105), NF-kappa B2 (p52 and its precursor p100), RelA (p65), RelB and c-Rel. The most studied dimer is p50:p65, which is activated by the classical pathway and usually promotes gene expression. Activation of p50:p65 is linked with cell survival and promoting inflammation. This review provides a detailed overview of the structure, synthesis and function of the lesser characterised NF-kappa B subunit; NF-kappa B1 (p 105 and p50). The diverse interactions of NF-kappa B1 with co-activators, co-repressors and other signaling networks that influence NF-kappa B1 gene expression are discussed. Finally the anti-inflammatory actions of NF-kappa B1 signaling will be assessed and the crucial need to design novel therapeutic drugs which exploit and amplify the anti-inflammatory actions of p50 will be explored. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1425 / 1430
页数:6
相关论文
共 25 条
[11]   I-KAPPA-B-GAMMA, A 70 KD PROTEIN IDENTICAL TO THE C-TERMINAL HALF OF P110 NF-KAPPA-B - A NEW MEMBER OF THE I-KAPPA-B FAMILY [J].
INOUE, J ;
KERR, LD ;
KAKIZUKA, A ;
VERMA, IM .
CELL, 1992, 68 (06) :1109-1120
[12]   Chronic inflammation and susceptibility to bacterial infections in mice lacking the polypeptide (p)105 precursor (NF-κB1) but expressing p50 [J].
Ishikawa, H ;
Claudio, E ;
Dambach, D ;
Raventós-Suárez, C ;
Ryan, C ;
Bravo, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (07) :985-996
[13]   Casper/c-FLIP is physically and functionally associated with NF-κBI p105 [J].
Li, ZQ ;
Zhang, JB ;
Chen, DY ;
Shu, HB .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 309 (04) :980-985
[14]   Cotranslational biogenesis of NF-κB p50 by the 26S proteasome [J].
Lin, L ;
DeMartino, GN ;
Greene, WC .
CELL, 1998, 92 (06) :819-828
[15]   Age-related neural degeneration in nuclear-factor κB P50 knockout mice [J].
Lu, Z. -Y. ;
Yu, S. P. ;
Wei, J. -F. ;
Wei, L. .
NEUROSCIENCE, 2006, 139 (03) :965-978
[16]   Nuclear factor-κB p50 limits inflammation and prevents lung injury during Escherichia coli pneumonia [J].
Mizgerd, JP ;
Lupa, MM ;
Kogan, MS ;
Warren, HB ;
Kobzik, L ;
Topulos, GP .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 168 (07) :810-817
[17]   The 20S proteasome processes NF-κB1 p105 into p50 in a translation-independent manner [J].
Moorthy, Anu K. ;
Savinova, Olga V. ;
Ho, Jessica Q. ;
Wang, Vivien Ya-Fan ;
Vu, Don ;
Ghosh, Gourisankar .
EMBO JOURNAL, 2006, 25 (09) :1945-1956
[18]   Nuclear factor-κβ1 (p50) limits the inflammatory and fibrogenic responses to chronic injury [J].
Oakley, F ;
Mann, J ;
Nailard, S ;
Smart, DE ;
Mungalsingh, N ;
Constandinou, C ;
Ali, S ;
Wilson, SJ ;
Millward-Sadler, H ;
Iredale, JP ;
Mann, DA .
AMERICAN JOURNAL OF PATHOLOGY, 2005, 166 (03) :695-708
[19]  
PERKINS ND, 2006, NAT REV, V8, P49
[20]   Gene deletion of NF-κB p105 enhances neointima formation in a mouse model of carotid artery injury [J].
Ruusalepp, Arno ;
Yan, Zhong-Qun ;
Carlsen, Harald ;
Czibik, Gabor ;
Hansson, Goran K. ;
Moskaug, Jan-Oyvind ;
Blomhoff, Rune ;
Valen, Guro .
CARDIOVASCULAR DRUGS AND THERAPY, 2006, 20 (02) :103-111